Fidelity International’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-146,089
Closed -$16.2M 1047
2019
Q4
$16.2M Buy
146,089
+294
+0.2% +$30.2K 0.02% 436
2019
Q3
$14.5M Hold
145,795
0.02% 429
2019
Q2
$14.5M Buy
145,795
+8,959
+7% +$855K 0.02% 418
2019
Q1
$15.1M Sell
136,836
-72
-0.1% -$7.53K 0.02% 398
2018
Q4
$12.6M Sell
136,908
-32,607
-19% -$3.3M 0.02% 414
2018
Q3
$18.7M Sell
169,515
-38,434
-18% -$4M 0.03% 402
2018
Q2
$19.4M Buy
+207,949
New +$17.9M 0.03% 399

Other funds holding PRAH

Fidelity International's PRAH Position: Q1 2020 in Review

Fidelity International sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2020, closing a stake of 146,089 shares — an estimated $16.2M sold.

Fidelity International first reported a position in PRAH in Q2 2018 and held it in 7 quarters. The position peaked at $19.4M in Q2 2018. 301 funds tracked by Wall St. Rank hold PRAH as of Q1 2020.

  • Fidelity International reported no remaining PRA Health Sciences, Inc. position as of Q1 2020 after selling out during the quarter.
  • Fidelity International sold 146,089 PRA Health Sciences, Inc. shares in Q1 2020, an estimated $16.2M.
  • Fidelity International first reported a position in PRA Health Sciences, Inc. in Q2 2018 and held it in 7 quarters.
  • Fidelity International's PRA Health Sciences, Inc. position peaked at $19.4M in Q2 2018.
  • 301 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2020.

Based on Fidelity International's 13F filing for Q1 2020, filed 14 May 2020.